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Abstract
Chicken meat with reduced concentration of arachidonic acid (AA) and reduced ratio between omega-6 and omega-3 
fatty acids has potential health benefits because a reduction in AA intake dampens prostanoid signaling, and the 
proportion between omega-6 and omega-3 fatty acids is too high in our diet. Analyses for fatty acid determination are 
expensive, and finding the optimal number of analyses to give reliable results is a challenge. The objective of the 
present study was i) to analyse the intraclass correlation of different fatty acids in five meat samples, of one gram each, 
within the same chicken thigh, and ii) to study individual variations in the concentrations of a range of fatty acids and 
the ratio between omega-6 and omega-3 fatty acid concentrations among fifteen chickens. Fifteen newly hatched 
broilers were fed a wheat-based diet containing 4% rapeseed oil and 1% linseed oil for three weeks. Five muscle 
samples from the mid location of the thigh of each chicken were analysed for fatty acid composition. The intraclass 
correlation (sample correlation within the same animal) was 0.85-0.98 for the ratios of total omega-6 to total omega-3 
fatty acids and of AA to eicosapentaenoic acid (EPA). This indicates that when studying these fatty acid ratios, one 
sample of one gram per animal is sufficient. However, due to the high individual variation between chicken for these 
ratios, a relatively high number of animals (minimum 15) are required to obtain a sufficiently high power to reveal 
significant effects of experimental factors (e.g. feeding regimes). The present experiment resulted in meat with a 
favorable concentration ratio between omega-6 and omega-3 fatty acids. The AA concentration varied from 1.5 to 2.8 
g/100 g total fatty acids in thigh muscle in the fifteen broilers, and the ratio between AA and EPA concentrations 
ranged from 2.3 to 3.9. These differences among the birds may be due to genetic variance that can be exploited by 
breeding for lower AA concentration and/or a more favorable AA/EPA ratio to produce meat with health benefits.
Background
The focus on meat with a composition adjusted to opti-
mize human health and life expectancy, initiates aware-
ness of meat fatty acid composition. Fatty acid analyses
are expensive and the number of samples available may
sometimes be limited. It is therefore important to know
the number of samples and animals needed for planning
an experiment with sufficient power to reveal relevant
effects of interest. It can be assumed that there will be
enhanced focus on the variation in fatty acid composition
between individual animals in a standardized environ-
ment, and on the potential to breed for a more favourable
fatty acid composition.
Chicken meat is commonly regarded as a healthy type
of meat; it is popular, and hence the consumption has
increased [1]. Chicken meat is lean, protein-rich and rich
also in other important nutrients. However, the fatty acid
composition is strongly dependent on the diet fed to the
birds. A typical modern poultry diet is rich in cereals hav-
ing a high ratio between omega-6 and omega-3 fatty
acids. This diet is very different from the natural diet for
the same species containing more green leaves that are
rich in the omega-3 fatty acid alpha-linolenic acid (ALA).
It has been shown that a diet rich in ALA gives increased
concentrations of ALA, eicosapentaenoic acid (EPA),
docosapentaenoic acid (DPA) and docosahexaenoic acid
(DHA) in broiler muscle and improved, i.e. reduced ratio
between total omega-6 and total omega-3 fatty acids [2,3].
The utilisation of ALA and linoleic acid (LA) for synthe-
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Page 2 of 11sizing EPA and arachidonic acid (AA) depends on feed
concentrations of ALA and LA as well as on other factors.
Much AA in the diet may contribute to prostaglandin
overproduction in disease situations in humans, but some
AA is necessary for virtually every body function. Dietary
sources of AA are especially meat, eggs and offal, with
smaller amounts coming from milk and fish.
Omega-6 and omega-3 fatty acids compete with each
other for incorporation into membrane lipids and also for
binding to several enzymes such as elongases, desatu-
rases, cyclooxygenases and lipoxygenases [4,5]. Omega-3
fatty acids also suppress the expression of inflammatory
genes, whereas omega-6 fatty acids have an opposite
effect [5]. Inflammation takes place within the vascular
walls and plays a role in modulating the effect of insulin
and control of inflammatory gene expression and lipid
metabolism [5]; it is therefore important not only in con-
nection with diabetes type 2, but also as a part of the dis-
ease mechanism during progression of atheromatosis/
atherosclerosis [5]. Omega-3 fatty acids decrease the
endothelial responsiveness to proinflammatory and
proatherogenic stimuli by modulating the expression of
adhesion molecules and cytokines important for the pro-
cesses collectively denoted as "endothelial activation" [6].
Because the magnitude of postprandial inflammation
(which is an independent risk factor for diseases such as
atherosclerosis and insulin resistance) depends on the
dietary ratio between omega-6 and omega-3 fatty acids,
and because each meal triggers an inflammatory
response, this ratio is also an important determinant of
the magnitude of the postprandial inflammatory
response [7]. In addition, the ratio between omega-6 and
omega-3 fatty acids also influences several processes at
the cellular level including rates of cell growth and prolif-
eration, and apoptosis versus cell survival [5].
In a recent study of the substrate specificities of
enzymes and prostanoid receptors, it was found that
COX-1 oxygenated EPA with only 10% of the efficiency of
AA [8]. It was also found that EPA is a comparatively poor
inhibitor of AA oxygenation by COX-2. It can be pre-
dicted from these and other observations that decreasing
the AA/EPA ratios in phospholipids of human cells will
reduce the production of 2-series prostanoids and
dampen prostanoid signalling. Because AA competes
with EPA and DHA as well as with LA, ALA and oleic
acid for incorporation in membrane lipids at the same
positions, all these fatty acids are important for control-
ling the AA concentration in membrane lipids, which in
turn determines how much AA can be liberated and
become available for prostaglandin biosynthesis follow-
ing phospholipase activation. Thus, the best strategy for
dampening prostanoid overproduction in disease situa-
tions would be to reduce the intake of AA, or reduce the
intake of AA at the same time as the total intake of com-
peting fatty acids (including oleic acid) is enhanced,
rather than enhancing intakes of EPA and DHA only.
Enhancement of membrane concentrations of EPA and
DHA will not be as efficient as a similar decrease in the
AA concentration for avoiding prostanoid overproduc-
tion.
Combining reduction of the intake of AA with
enhancement of the intake of oleic acid will, moreover,
also be a better strategy for reducing the total extent of in
vivo lipid peroxidation, rather than adding more EPA
(with 5 double bonds) and DHA (with 6 double bonds) to
a diet already over-abundant in arachidonic acid and lino-
leic acid. A reduction of the dietary ratio of total polyun-
saturated fatty acids to oleic acid will not only make
plasma lipoproteins less vulnerable to oxidation [9,10],
but must also be expected to lead to reduction of the rate
of formation of mutagenic aldehydes that arise as second-
ary products of lipid peroxidation, such as malondialde-
hyde, crotonaldehyde, acrolein and 4-hydroxynonenal
[11]. High rates of production of these mutagenic alde-
hydes must be expected simultaneously to lead to
enhancement of the risk of various forms of cancer (11),
and enhancement of the rate of mitochondrial DNA
aging, which could lead to earlier onset of various age-
associated degenerative diseases perhaps including type 2
diabetes. The degree of fatty acid unsaturation of mito-
chondrial membrane lipids has been found to be one of
those biochemical parameters that are most strongly cor-
related with longevity, when different species of mam-
mals and birds are compared, with a low degree of fatty
unsaturation being correlated with less lipid peroxidation
and a longer normal life-span [12]. Oxidatively modified
LDL is much more atherogenic than non-modified LDL
[13]. Oleic acid has, moreover, also been reported to have
antiatherogenic protective effects on endothelial cells by
reducing rates of intracellular generation of reactive oxy-
gen species (ROS) [14] and counteracting the activation
of nuclear factor-kappaB [15].
On the other hand, it is also important that the intake
of long-chain omega-3 fatty acids should not be too low,
given the specific protective roles of these fatty acids
against sudden cardiac death [16], and the important role
of DHA as a structural component of membrane lipids in
the brain [17].
The ratio between concentrations of omega-6 and
omega-3 fatty acids, especially the AA/(EPA + DHA)
ratio, is too high in the western diet, and a lower ratio
between omega-6 to omega-3 fatty acids is desirable
because it may help to reduce the prevalence and/or mor-
bidity of chronic inflammatory diseases and atherosclero-
sis [18]. Therefore, we think that all chicken meat
available for human consumption should have a favour-
able ratio between omega-6 and omega-3 fatty acids,
especially when considering the long-chain ones, such as
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of AA in animal products such as meat, eggs and offal is
desirable. At the same time, it would probably also be an
advantage if the ratio of oleic acid to sum polyunsaturated
fatty acids (especially the oleic acid acid/LA ratio) in
these products could be even higher than it is now. This
would be expected to improve the storage stability for
chicken meat and offal in contact with air (not being
stored under inert gas), if they shall contain much more
EPA and DHA than now.
Since the sources of the long-chain omega-3 fatty acids
EPA, DPA and DHA seem to be limited because of eco-
logical limits of total fish production in the sea and a ten-
dency for overfishing of many important fish stocks [19],
every step towards increasing the concentration of these
fatty acids in the regular human diet from sources other
than seafood is of importance.
Chicken meat with a low AA concentration and a
favourable ratio between omega-6 and omega-3 fatty
acids may be desirable not only for prophylactic reasons
(in order to reduce morbidity and mortality from several
important diseases in the general population), but also for
making it easier to optimize the composition of the total
diet for patients suffering from serious diseases such as
cancer, coronary heart disease, rheumatoid arthritis or
HIV disease (with the aim of reducing the production of
eicosanoids that can be harmful for patients suffering
from these diseases, rather than relying on drugs - with
their side effects - alone for achieving the same). The
same would also be the case for patients suffering from
various common forms of pain, e.g. because of skeleto-
muscular disorders.
Increasing the long-chain omega-3 fatty acids EPA and
DHA intake through the ordinary diet is also a better
strategy than relying on fish oil capsules or fish alone,
especially when one wishes to reach the entire popula-
tion. Intake through ordinary foods will be associated
with less risk of EPA and DHA peroxidation during stor-
age, compared with fish oil capsules (since rancidification
of foods is very easily detected by consumers and an
important reason for not eating the food, while the same
may not be the case for fish oil inside a capsule). Also
when EPA and DHA come from animal foods rather than
as purified dietary supplements, they will be ingested
together with antioxidant nutrients that are important for
prevention of peroxidation in vivo, such as selenium, glu-
tathione (plus glutathione precursor amino acids), car-
nosine and taurine. These antioxidant nutrients (with
antioxidant properties protecting against tissue damage
caused by ischemia and reperfusion) may themselves
have important antimutagenic, anticarcinogenic, and
anti-inflammatory properties and may very likely syner-
gize with many of the protective effects of long-chain
omega-3 fatty acids.
The purpose of the present study was i) to analyse the
intraclass correlation of different fatty acids in five meat
samples weighing one gram within the same chicken
thigh, and ii) to study individual variations in the concen-
trations of a range of fatty acids and the ratio between
omega-6 and omega-3 fatty acid concentrations among 15
chickens. This ratio may not only depend on the fatty acid
composition of the feed, but also on genetic factors, thus
opening for an opportunity of breeding for animals with
less AA and better omega-6/omega-3 ratio in the meat.
Materials and methods
Animal care
The experimental research on animals followed interna-
tionally recognized guidelines. All animals were cared for
according to laws and regulations controlling experi-
ments with live animals in Norway (The Animal Protec-
tion Act of December 20th, 1974, and the Animal
Protection Ordinance Concerning Experiments with
Animals of January 15th, 1996), according to the rules
given by Norwegian Animal Research Authority.
Feeding experiment
Fifteen newly hatched male broilers with different
unknown dams and sire(s) (Ross 308, Samvirkekylling,
Norway) were fed a wheat based diet. During the first 10
days the birds were kept in a deep littered pen; 75 cm ×
150 cm. At day 10, each individual was weighed and the
birds were placed in separate metabolism cages. They
were raised in wire-floored battery brooders in an envi-
ronmentally controlled room with electrical heating. The
room temperature was maintained at 32°C from days 0-3,
and then gradually reduced by 0.5°C per day until day 21.
The chicks were exposed to 23 h light and 1 h dark photo-
period during days 0-7. The next two weeks they were
exposed to 2 × 4 h dark; the dark periods were between
17-21 h and 00-04 h. The birds had free access to water.
Water troughs were cleaned daily. At day 21, the birds
were weighed and killed by exposure to CO2 gas for 2 min
in a flow-through system. One thigh was immediately




The diet included wheat (60%), soybean meal (20%), fish
meal (3%), rapeseed oil (4%, Askim Bær- og fruktpresseri,
Askim, Norway), linseed oil (1%, Dr. Lindbergs, Oslo,
Norway), and nutrient supplements (A/S Norsk Mineral-
næring, Hønefoss, Norway). Organic selenium enriched
yeast (BioLogics, Ultra Bio-Logics Inc. New O.S.Y. 2000X,
containing 2.15 g Se/kg) was added to the diet, giving 0.78
mg/kg diet. Diet composition was 60% Wheat, 20% Soy-
bean meal, 3% Fish meal, 4% Rapeseed oil, 1% Linseed oil,
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stone, 0.25% Sodium chloride, 0.40% DL-Methionine,
0.30% L-Lysine, 0.10% L-Threonine, 0.13% Choline chlo-
ride, 0.007% Manganese oxide, 0.04% Se-enriched yeast,
0.15% Mineral mixture, 0.08% Vitamin mixture, (the vita-
min and mineral mixture provided per kg diet: retinyl
acetate, 2.7 mg; cholecalciferol, 0.07 mg; DL-alpha
tocopheryl acetate, 38 mg; menadione, 2.25 mg; pyridox-
ine, 3.4 mg; riboflavin, 9 mg; Ca-pantothenate, 12.5 mg;
biotin, 0.19 mg; thiamine, 1.9 mg; niacin, 37.5 mg; cobala-
mine, 0.02 mg; folic acid, 1.5 mg; choline chloride, 500
mg; manganese, 75 mg; zinc, 75 mg; iron, 95 mg; copper,
10 mg; iodine, 0.6 mg).
The wheat was ground on a hammer mill, 3 mm sieve.
The feed was manufactured at ForTek, Ås, Norway, with
matrix type 2.5 m m × 46 m m. 600 kg/hour, cold pelleta-
tion.
The fatty acid concentration of the diet (g/100 g fat)
were: C16:0, 14.3; C18:0, 8.3; C18:1, c9, 37.1; C18:2, n-6,
19.8; C18:3, n-3, 9.0; C20:4, n-6, 0.09; C20:5, n-3, 0.17;
C22:5, n-3, 0.06; C22:6, n-3, 0.29.
Laboratory analyses
Fatty acid analyses and determination of fat percent in 
muscle
Fatty acid composition of five parallel samples, each
weighing about one gram from the middle of the thigh
from each of the fifteen individuals was determined by
gas chromatography. Lipid extraction and direct methyla-
tion was performed according to O'Fallon et al. on muscle
tissue and feed [20]. Subsequently, the fatty acid methyl
esters were analyzed with a 6890N GC with a split/split-
less injector, a 7683B automatic liquid sampler, and flame
ionization detection (Agilent Technologies, Palo Alto,
CA). Separation was performed with a CP-SELECT CB
FOR FAME (200 m × 0.25 mm i.d. × 0.25 μm film thick-
ness) fused silica capillary column (Varian Inc.). Temper-
ature program, initial: 70°C with 4 min hold, ramp 20°C/
min to 160°C, 3°C/min to 230°C with 15 min hold. The
carrier gas was H2, and a pressure of 309.4 kPa was used.
Fatty acid analysis was performed by autoinjection of 1
μL of each sample at a split ratio of 30:1, a H2 flow of 68.4
ml/min and a temperature of 280°C. The flame ionization
detector temperature was 290°C with H2, air and N2
make-up gas flow rates of 40, 450 and 45 ml/min respec-
tively. The sampling frequency was 10 Hz. The run time
for a single sample was 91.83 min. Fatty acid peaks deter-
mined by gas chromatography were then used to calcu-
late the amounts of fatty acids (g/100 g fat) by theoretical
response factors [21]. Considering minoritary fatty acids
the "noise" in the baseline of the GC analyses may con-
tribute relatively more to intraassay variability. Standard
fatty acids of known composition were run to identify the
fatty acids in the samples. Muscle control samples were
extracted, methylated and analysed by every 10th sample.
Determination of fat percentage in muscle
The percentage of fat was determined in thigh muscle by
ASE, Dionex, USA, application note 329, Dionex.
Statistical Analyses
A one-way ANOVA was carried out for estimating the
animal and residual variance components of concentra-
tions and ratios of the fatty acids in the muscle samples
using the GLM procedure of the SAS software [22]. The
following model was assumed:
where yij is the fatty acid observation of the jth sample
of the ith individual, μ is overall mean, ai is the random
effect of the ith animal and eij is the random residual
error for the jth sample of the ith individual. For each
fatty acid character the intraclass correlation was esti-
mated as:
where σa2 and σe2 are estimated animal and residual
variance components, respectively.
The correlation coefficients were estimated by the cor-
relation function in Microsoft Excel.
Results and discussion
Final body weight of the broilers (21 days old when
slaughtered) was 928 g, which is as expected for 21 days
old broilers, and similar to previous studies [3,23]. None
of the birds died during the experiment. The mean fat
percent in thigh muscle was 2.4 g/100 g muscle.
Mean concentrations of fatty acids in the 15 broiler thighs
The mean concentrations of the various fatty acids in
broiler thigh in the 15 birds and the standard deviation
(SD) are shown in Table 1. The main fatty acids in broiler
thigh were oleic acid, palmitic acid, LA and stearic acid
(Table 1). alpha-Linolenic acid was also a relatively abun-
dant fatty acid. The results are comparable to a previous
study [3]. The ratios between the omega-6 and omega-3
fatty acids (n-6/n-3 and AA/EPA) are also shown in Table
1. The ratio between omega-6 and omega-3 fatty acids in
chicken thigh is reported to be in the range 8-13:1 [24,25].
In the present study, with experimental diets containing
4% rapeseed oil and 1% linseed oil, the broiler thigh meat
had a much lower and more favorable ratio between total
omega-6 and omega-3 fatty acids; being about 2:1, and the
ratio between AA and EPA was about 3:1. The ratio
between AA and EPA was 2.3:1 in the bird with the low-
yij ai eij= + +m ,
r a a e= +s s s2 2 2/ ( ),
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ference in about 70% which shows that there is a
significant variation among the individuals. It is also
interesting to note the concentration of AA varying from
1.5 to 2.8 g/100 g fatty acids in thigh muscle in the fifteen
broilers. Because the feed composition was the same, it is
a reasonable assumption, or working hypothesis, that this
variation may have genetic causes.
This could open for the possibility to breed for chicken
that for a given diet composition will have a lower con-
centration of AA and a lower EPA/DHA ratio in their
meat - in which there seems to be a big potential to make
the chicken meat even better for the health of the con-
sumer.
Intraclass correlations and individual variance between 
birds
Estimated intraclass correlations and between bird vari-
ance components are shown in Table 1. For two of the
fatty acids; palmitic acid (16:0), and linoleic acid (LA) the
intraclass correlation was very high. The ratio between
AA and EPA and between total omega-6 and total omega-
3 fatty acids also shows high intraclass correlation, dem-
onstrating that only one sample, weighing one gram, from
each thigh and individual will be sufficient for studying
these characteristics as very little can be gained by adding
an extra sample. However, due to the high variation
between individual animals, about 15 animals should be
sampled in each group in order to compare different
group means with respect to these ratios of fatty acids.
For myristic acid (14:0), stearic acid (18:0) and ALA
(18:3 n-3) the intraclass correlation was moderate, but for
the fatty acids found in low concentrations; EPA, DHA,
DPA and AA, and for oleic acid (18:1 c 9) the intraclass
correlation was lower. For these fatty acids, adding an
extra sample for analyses from each individual thigh will
contribute to increase the power of an experimental study
considerably, especially when number of animals per
experimental group is low. For example, for oleic acid
with intraclass correlation of 0.3, the power of a statistical
test (chance that a real difference of 10% is within a 95%
confidence interval and hence revealed) of a comparison
of two experimental groups of 5 animals increases from
0.74 to 0.90 and 0.95 by adding one or two extra sample(s)
per thigh, respectively. Hence, the number of animals in
the experiment can be kept low. If only one sample is
taken from each animal, we will need 8-10 animals to
obtain the same power. This is contrary to e.g. LA with an
intraclass correlation of 0.9. Here, very little is gained by
adding one or 20 extra sample(s) as e.g. power increase
from 0.80 to 0.82 and 0.84, respectively, when sampling 5
animals per group. Hence, due to the large between ani-
mal variance, number of experimental animals per group
has to be increased to 7 to reach a power of 0.9.
In a previous study where chickens were fed either a
diet containing 4% rapeseed oil plus 1% linseed oil (as the
present study) or a diet containing 5% rapeseed oil, the
fatty acid composition in thigh muscles were compared.
The difference in mean concentration of LA between the
dietary treatment groups was less than 10% (15.5 g/100 g
fat and 16.4 g/100 g fat) but the difference between the
groups was highly significant (P = 0.001) [3].
In order to perform a test of principle we used example
data (unpublished data) of two groups of chicken, each of
Table 1: Fatty acid composition (g/100 g fatty acids) of chicken thigh muscle. 
Mean SD re
C14:0 0.66 0.053 0.49
C16:0 16.03 0.74 0.93
C16:1 c9 2.46 0.47 0.71
C18:0 8.91 0.74 0.50
C18:1 c9 32.98 2.02 0.30
C18:2 n-6, LA 15.45 0.93 0.92
C18:3 n-3, ALA 4.61 0.49 0.43
C20:4 n-6, AA 2.34 0.42 0.34
C20:5 n-3, EPA 0.84 0.15 0.37
C22:5 n-3, DPA 1.58 0.31 0.37
C22:6 n-3, DHA 1.63 0.35 0.40
AA/EPA 2.81 0.46 0.98
n-6/n-3 2.15 0.10 0.85
Mean, standard deviation (SD) and intraclass correlation (re) (n = 15 animals × 5 samples per animal).
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and 1% linseed oil, or a diet containing 5% rapeseed oil.
The mean concentration of oleic acid, AA, EPA and DPA
in breast muscle differed on average with 19% (10-47%)
between the groups, which was significant (P < 0.025-
0.0001). When splitting the 15 animals per group ran-
domly into three subgroups of 5 animals per subgroup,
only 42% of the 12 t-tests (4 fatty acids × 3 subgroups/
data) for the dietary treatments were able to reveal signif-
icant differences (P < 0.05). For compatible t-tests of
dietary treatments for LA and the ratios AA/EPA and n-
6/n-3, showing 4%, 47% and 66% differences, respectively
(on average 29% difference), 67% of the nine t-tests (3
fatty acid or ratios × 3 subgroups/data) were significant
(P < 0.05). When increasing number of chickens per
group to seven and eight per subgroup, 63% of the eight t-
tests (3 fatty acids × 2 subgroups/data) of the low intrac-
lass correlated fatty acids (oleic acid, AA, EPA and DPA)
were significant. The compatible percentage for the high
intraclass correlated fatty acid and ratios (LA, AA/EPA
and n-6/n-3) increased to 83%, showing a slightly lower
increase in power by increasing number of animals com-
pared to the low intraclass correlated fatty acids. The
level of mean differences of the fatty acids varied between
the low and high intraclass correlated fatty acids (29%
versus 19%), but the large differences were accompanied
with very low standard errors, yielding a high level of sig-
nificance (P < 0.0021 for five of the six significant t-tests).
For the low intraclass correlated fatty acids, the results
showed that tests of dietary effects based on five animals
per diet are very poor, and that increasing number of ani-
mals from five to seven or eight animals will give much
more powerful tests.
Correlation coefficients
The associations (correlation coefficients) between vari-
ous fatty acids are shown in Table 2, showing that the
concentration of the dominant fatty acid in broiler mus-
cle, oleic acid (33% of the fatty acid methyl esters) is
strongly and positively correlated to those of the mono-
unsaturated fatty acids 16:1 c9 and also to 14:1 c9 (not
shown in table). These are all fatty acids produced by
desaturation with the delta-9 desaturase enzyme. There
is also a strong but negative association between oleic
acid and stearic acid. This can be explained by the fact
that stearic acid is converted to oleic acid by the delta-9
desaturase enzyme. Oleic acid also correlates highly neg-
atively to the C20 and C22 fatty acids and positively to the
calculated ratios LA to AA, ALA to EPA, ALA to DPA,
ALA to DHA and ALA to LA. This suggests that oleic
acid might inhibit elongation/desaturation processes
either directly (e.g. as a competitive inhibitor of linoleoyl-
CoA and alpha-linolenoyl-CoA formation) or by some
indirect mechanism. It has been suggested that conver-
sion of fatty acids to their long-chain highly unsaturated
products is stimulated in situations when there is a defi-
ciency of antioxidants [26]. Our observations are compat-
ible with these observations, as oleic acid is a stable fatty
acid not triggering oxidative stress. But the hypothesis
that oleic acid functions as a competitive inhibitor of LA
and ALA conversion into long-chain polyunsaturated
fatty acids (perhaps especially at the very first step of the
pathways concerned, but quite plausibly also at the next
one, i.e. that of fatty acyl-CoA elongation), would appear
equally plausible.
In the same manner as oleic acid, ALA also shows a
negative association to the C20 and C22 fatty acids, and
positive association to the calculated ratios LA to AA,
ALA to EPA, ALA to DPA, ALA to DHA and ALA to LA.
This, however, must have a different explanation, because
ALA with its three double bonds is not a fatty acid that
can contribute to protect membrane lipids against perox-
idation, as oleic acid does. We shall return to this ques-
tion later.
Stearic acid, being negatively correlated to oleic acid,
shows a positive association to fatty acids with 20 and 22
C-atoms, both omega-3 and omega-6, and a negative
association to the calculated concentration ratios LA to
AA, ALA to EPA, ALA to DPA, ALA to DHA and ALA to
LA, indicating that either a high level of stearic acid per se
or less conversion of stearic acid to oleic acid (functioning
as an inhibitor) might favor conversion of LA and ALA
into the long 20 and 22 C fatty acids. The C20 and C22 n-
6 and n-3 fatty acids are all positively correlated to each
other, indicating that they might be controlled in a similar
way by the same genetically variable factors (which e.g.
might be a genetically controlled difference in the expres-
sion of one or more enzymes in the pathway of LA and
ALA conversion into the corresponding C20 and C22
fatty acids, but also a genetically controlled difference in
the rate of conversion of stearic acid into oleic acid).
The observed positive correlation between the omega-6
fatty acid AA and the omega-3 fatty acids EPA, DPA and
DHA might indicate that the genetic regulation of the
expression or activity of the elongases and desaturases
may covariate with both the conversion of the omega-6
fatty acid LA to AA and of the omega-3 fatty acid ALA to
EPA, DPA and DHA (Table 2). These fatty acids compete
in binding to enzymes. However, the positive association
between AA and EPA, DPA and DHA shows that the
desired reduction in AA will also be followed by a reduc-
tion in EPA, DPA and DHA.
The intraclass correlation indicates the maximum level
of heritability of a trait. Because the feed composition
was identical for all animals, it may be speculated
whether some of the individual variation may be due to
genetic factors implying differences in the kinetic proper-




















































Table 2: Coefficients of correlations between fatty acids and some fatty acid ratios in chicken thigh muscle (n = 15).
C16:0 C16:1 c9 C18:0 C18:1 c9 C18:2 n6 C18:3 n3 C20:4 n6 C20:5 n3 C22:5 n3 C22:6 n3 AA/EPA n-6/n-3 LA/AA ALA/EPA ALA/DPA ALA/DHA ALA/LA
C16:0 1,00
C16:1 c9 0,56 1,00
C18:0 -0,18 -0,79 1,00
C18:1 c9 0,09 0,73 -0,86 1,00
C18:2 n6 -0,83 -0,66 0,26 -0,25 1,00
C18:3 n3 -0,35 0,27 -0,72 0,70 0,38 1,00
C20:4 n6 -0,40 -0,76 0,85 -0,84 0,29 -0,65 1,00
C20:5 n3 0,26 -0,31 0,64 -0,79 -0,24 -0,86 0,63 1,00
C22:5 n3 -0,10 -0,58 0,73 -0,89 0,03 -0,73 0,86 0,84 1,00
C22:6 n3 -0,07 -0,69 0,80 -0,91 0,14 -0,68 0,85 0,63 0,82 1,00
AA/EPA -0,78 -0,53 0,24 -0,09 0,65 0,23 0,45 -0,40 0,03 0,28 1,00
n-6/n-3 -0,60 -0,29 0,15 0,14 0,66 0,24 0,05 -0,36 -0,34 -0,24 0,50 1,00
LA/AA 0,14 0,63 -0,85 0,85 -0,03 0,82 -0,95 -0,77 -0,89 -0,86 -0,23 0,13 1,00
ALA/EPA -0,30 0,37 -0,75 0,81 0,26 0,93 -0,67 -0,96 -0,82 -0,69 0,33 0,31 0,83 1,00
ALA/DPA -0,02 0,57 -0,81 0,89 0,03 0,85 -0,84 -0,89 -0,94 -0,81 0,04 0,25 0,94 0,93 1,00
ALA/DHA -0,11 0,63 -0,87 0,89 0,00 0,83 -0,79 -0,73 -0,78 -0,94 -0,10 0,20 0,88 0,83 0,87 1,00
ALA/LA 0,11 0,65 -0,89 0,89 -0,16 0,85 -0,86 -0,79 -0,81 -0,81 -0,12 -0,10 0,89 0,83 0,88 0,87 1,00
LA; Linoleic acid. ALA; alpha-linolenic acid. AA; arachidonic acid. EPA; eicosapentaenoic acid.
DPA; docosapentaenoic acid. DHA; docosahexaenoic acid.
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Page 8 of 11desaturases) that participate in the conversion of LA and
ALA to the corresponding long-chain fatty acids. How-
ever, there may also be differences in the rate of fatty acid
consumption as metabolic fuels.
The strongly negative correlation found between ALA
and long-chain omega-3 fatty acids could possibly be
explained assuming a strong preference for ALA com-
pared to LA at the start of the biochemical pathway of
conversion of these fatty acids to the corresponding long-
chain fatty acids. Animals with more rapid beta-oxidation
of C18 polyunsaturated fatty acids might then contain
less LA and AA, while animals with more rapid conver-
sion of C18 polyunsaturated fatty acids to corresponding
C20 and C22 fatty acids will contain less ALA and more
EPA and DHA. It is not unreasonable that there might be
a preferential conversion of ALA (rather than LA) con-
version into long-chain fatty acids in poultry, given the
importance of DHA for the normal function of the cen-
tral nervous system [27] that is presumably not much dif-
ferent in birds compared with humans and also the high
omega-6/omega-3 fatty acid ratio of many seeds that may
be important as food for birds living in their natural habi-
tats.
It is possible that there is a similar preference for ALA,
compared to LA, by enzymes of the elongase-desaturase
pathway also in humans, as suggested by the much lower
ALA/LA concentration ratio in human blood samples
from the population in Crete, compared to olive oil [28].
In this study they found that the plasma lipoprotein cho-
lesteryl ester contained 11.1 +/- 1.0 palmitic acid, 31.0 +/-
2.7% oleic acid, 41.9 +/- 3.7% LA and only 0.9 +/- 0.5%
ALA. It would appear more plausible to explain the much
lower ALA/LA ratio found in human blood cholesteryl
esters than in the traditional diet at Crete as a conse-
quence of preferential conversion of ALA into EPA, DPA
and DHA, rather than as a consequence of more rapid
beta-oxidation of ALA compared to LA. This hypothesis
implies that there must be a high degree of ALA conver-
sion into long-chain omega-3 fatty acids in humans,
which is in conflict with research reports suggesting very
poor conversion of ALA into EPA and DHA in humans
[29,30]. Literature data in this field are not consistent;
since some groups [31] have found considerably better
conversion than others have done. It may be questioned if
this might reflect variations in the intake of some uniden-
tified nutrient cofactor needed for normal conversion of
ALA into EPA and DHA. One possible (but entirely
hypothetical) candidate is the trace element vanadium,
since the bioavailability of this element for uptake into
plant roots is heavily dependent on redox conditions in
the soil, and it is not unreasonable that the dietary intake
of vanadium could be much higher in Crete than in Can-
ada (because of higher soil temperature and lower
organic matter concentrations combined with higher
average pH in the soils in Crete). This trace metal has also
more general chemical properties (redox behaviour, ionic
radii and coordination chemistry in crystals and com-
plexes) that could make it potentially useful as a catalyst
of fatty acid desaturation reactions, and there are obser-
vations from animal experiments suggesting that vana-
dium deficiency may cause disturbances in lipid
metabolism [32].
An alternative hypothesis for explaining our own
observations would be to postulate a genetic variance in
the substrate specificity (for ALA versus LA) of the
enzyme at the start of the pathway of C18 polyunsatu-
rated fatty acid conversion into corresponding C20 poly-
unsaturated fatty acids. This hypothesis is not
implausible from the evolutionary point of view because
it could offer a good mechanism of genetic adaptation of
animals to different types of environment or ecological
niches, where the food available has significantly different
overall omega-6/omega-3 fatty acid ratios.
If such genetic differences in the metabolic conversion
of C18 fatty acids into C20 and C22 fatty acids do indeed
exist, this could obviously be of health-economic rele-
vance in our society. In the present situation, when poul-
try is most commonly given a feed with very high LA/
ALA ratio, it would be an advantage for the consumer if
the animals have a poor conversion of LA into AA. How-
ever, if regulations should be imposed by the health
authorities in Norway or other countries, requiring that
the overall LA/ALA ratio in poultry feed should not be
higher than perhaps 2/1, we would rather desire that as
much as possible of the ALA in the feed could be con-
verted into EPA and DHA.
Our data indicating genetic variation in fatty acid
metabolism in chicken are in partial agreement with ear-
lier reports. De Smet et al. [33] concluded in a review that
there may some degree of genetically controlled variation
in the concentrations of monounsaturated and saturated
fatty acids among individuals after correcting for fat level.
However, they suggested that enzyme activities were not
able to explain between-animal variation in fatty acid
composition [33].
While the most important method for optimizing the
fatty acid composition of poultry meat still must be to
optimize the fatty acid composition of the feed, we can
not exclude the possibility that some improvement could
be obtained through breeding efforts. Especially it might
be possible to change the substrate specificity of some of
the enzymes concerned for more efficient conversion of
ALA and less efficient conversion of LA into the corre-
sponding long-chain polyunsaturated fatty acids.
An optimization of the fatty acid composition of the
total human diet - not only at the level of individuals, but
also at a population level - is important. The proportions
between the C18 acids oleic acid, LA and ALA in the total
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Page 9 of 11diet are heavily dependent on consumption levels and the
fatty acid composition of various edible fats and oils.
Intakes of AA, EPA, DPA and DHA are mainly deter-
mined by the intake level and fatty acid composition of
various fish- and other animal foods, as well as by the
consumption of dietary supplements (especially in form
of cod-liver oil and fish oil capsules).
A high absolute intake of AA is directly associated with
a tendency for prostaglandin and thromboxane overpro-
duction. Thromboxane A2, which is a potent vasocon-
strictor and platelet aggregator [34], is mainly produced
in the platelets, where COX-1 is constitutionally
expressed. It was earlier thought that thromboxane A3 is
inactive. This has now been shown not to be correct [8].
However, the rate of EPA oxidation by COX-1 is only 10%
of the rate of AA oxidation [8], which can still help to
explain why a high dietary ratio of EPA to AA is anti-
thrombotic, while a high dietary intake of AA enhances
the risk of thrombotic events. This will especially be the
case when simultaneously a combination of high rates of
reactive oxygen species (ROS) production, e.g. as a conse-
quence of hyperglycemia or hypertension [35-37], and
poor antioxidant defense capacity in blood plasma and
the endothelial cells, e.g. because of selenium depletion
[38-40] or glutathione depletion [14,15,41,42], leads to
inhibition of endothelial prostacyclin synthetase by per-
oxynitrite [43] or fatty acid hydroperoxides [44], so that
thromboxane A2 production in activated platelets will be
high at the same time as prostacyclin production in the
endothelium is depressed. Prostacyclins (PGI2 and PGI3)
are at the same time very potent vasodilators and very
potent inhibitors of platelet aggregation [34], and it is
therefore strongly dependent on the thromboxane/pros-
tacyclin balance whether platelet-initiated or vascular
wall-initiated thrombosis will occur or not.
Chicken meat with a low AA/(EPA + DHA) ratio would
be expected not only to improve the AA/(EPA + DHA)
ratio in membrane lipids both in the endothelium and
platelets, but also (and in contrast to fish oil capsules) to
counteract glutathione depletion in the same cells, e.g. in
patients suffering from acute or chronic infectious dis-
ease or other protein catabolic conditions - in which case
not only the total rate of protein catabolism is enhanced
[45], but also the rate of degradation of sulphur amino
acids [46,47]. A similar doubly protective effect must also
be expected for fat fish products, such as mackerel and
herring, and for products made from whole fish, such as
dried kapenta and fish protein concentrate type B (FPC
type B) [48]. Most fish products have also important anti-
oxidative protective effects because of their high sele-
nium concentration [49,50]. In poultry meat it is possible
to achieve a similar selenium/protein concentration ratio
as in fish by adding selenomethionine rather than sodium
selenite to the feed [3].
Disease situations where COX-2 is important include
many (but far from all) cases of cancer, including a sub-
stantial proportion of patients with colorectal cancer,
breast cancer, lung cancer and prostate cancer [51]. COX-
2 is, moreover, also important in various chronic non-
infectious inflammatory diseases, such as rheumatoid
arthritis [34], and in pain conditions attending skeleto-
muscular disorders. There are many reasons why it is
important to limit prostaglandin production in tumors
expressing COX-2. Prostaglandin E2 (PGE2), which is
abundantly produced in such tumors [52], stimulates
tumor angiogenesis [52], i.e. the ingrowth of blood vessels
in the tumor [52,53], which will in turn reduce oxygen
and nutrient limitation [54] of the rate of tumor growth,
thus leading to faster progression of the disease. PGE2
also inhibits NK cells [55], lymphokine-activated killer
(LAK) cells [56] and cytotoxic CD8+ cells [57], which all
are important in anti-tumor immunological defense
[55,58,59], at the same time as prostaglandin overproduc-
tion in the tumor also must be expected to increase pain
associated with cancer.
There are therefore several good reasons not only to
enhance dietary intakes of EPA and DHA, but also to
limit the dietary intake of AA in all such cases of cancer
where the tumor cells express COX-2. Patients with
COX-2-expressing tumor cells should therefore be told to
avoid poultry meat, swine meat and egg with high AA/
(EPA + DHA) ratios. But all these foods would probably
be safe for cancer patients to eat if they had a more natu-
ral fatty acid composition than is common in most of the
western world (including both North America and West-
ern Europe) today. At the same time, it should not be for-
gotten that anti-tumor immunological functions - that
overlap strongly with NK-cell- and T-cell-mediated func-
tions important for antiviral immunological defense -
also depend on glutamine, glutathione and selenium sta-
tus [60,61]. As an example can be mentioned that NK
cells normally will secrete the Th1-associated cytokine
interferon-gamma following simultaneous stimulation
with interleukin-12 (IL-12) and interleukin-2 (IL-2), pro-
vided that they are not glutathione-depleted [62]. But
glutathione-depleted NK cells will instead secrete the
Th2-associated (and Th1-inhibitory) cytokine interleu-
kin-10 (IL-10) following double stimulation with IL-12
and IL-2 [62].
Thus the broiler meat in the present study could be a
healthful element of the human diet, since it may not only
help to increase the intakes of EPA, DPA and DHA from
ordinary foods, but also to decrease the intake of arachi-
donic acid that is now too high in much of the western
world, at the same time as it also functions as a good
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protection in endothelial cells and platelets (and thus for
prevention of atheromatosis and thrombosis), as well as
being important for immunological defense both in infec-
tious diseases and cancer.
Conclusion
We have found that a broiler feed containing 4% rapeseed
oil and 1% linseed oil/kg diet gave a meat that was charac-
terized by a favourable ratio between AA and EPA of
about 3:1. Moderate to high intraclass correlations (0.30-
0.92) were estimated for all the fatty acids analyzed, and
particularly high estimates were obtained for the ratios of
AA/EPA and n-6/n-3 (0.85-0.98) indicating a potentially
high heritability. The ratio between AA and EPA was
2.3:1 in the bird with the lowest ratio and 3.9 :1 in the bird
with the highest ratio. The estimated intraclass correla-
tion for AA was much lower (0.34), but still the concen-
tration of AA varied from 1.5 to 2.8 g/100 g fatty acid in
thigh muscle in the fifteen broilers. Thus breeding for
healthier meat containing low AA concentration and low
AA/EPA ratio in chicken meat may be possible. One
thigh muscle sample of one gram was enough to give reli-
able estimates of the AA/EPA ratio and omega-6/omega-3
ratio of a chicken thigh. For the trustworthy absolute con-
centration of AA, EPA, DPA and DHA, adding one (or
more) sample(s) of one gram thigh meat sample will con-
tribute significantly to reduce standard errors of the esti-
mates, and improve the power of experimental studies,
especially when the number of animals per group is low.
For the fatty acids and fatty acids ratios with high intrac-
lass correlations (C16:0, LA, AA/EPA and n-6/n-3), only
one sample per animal is enough, but higher number of
animals (about 15 animals) is needed per experimental
group to be compared.
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